Cellergy Pharma, a rising cellular therapies biotechnology company, has been awarded $300,000 to fuel the development of therapies to treat severe allergic diseases.
© 2024 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.